Flt 3 inhibitors (Sareum)

N/A

Report date: 2025/03/20 14:53:10
NME

Base Information

Drug NameFlt 3 inhibitors (Sareum)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsAutoimmune DiseasesLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSareum Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesSareum Holdings plc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A